Thomas Lienard is a highly accomplished business executive with extensive experience in the biotech and pharmaceutical industries. He has held several leadership positions, including Chief Executive Officer at Bio-Life and Chief Executive Officer and Board Member at Bone Therapeutics. Thomas studied at prestigious universities such as Harvard Business School, Solvay Brussels School, and McGill University, earning his Master's degrees in Business Administration and Engineering.

Before joining Bio-Life, Thomas worked as Managing Director for Belgium-Luxembourg at Lundbeck and held several positions at Eli Lilly And Company, including Sales Director, District Sales Manager, and International Marketing Associate. Additionally, he was an Associate at McKinsey & Company, where he gained valuable consulting skills.

Thomas has an outstanding track record in the development and commercialization of innovative drugs, as well as in business strategy and management. With his broad knowledge of the industry, he has also served as Chairman of the Board at Antigon and as a Board Member at Wishbone Biotech. His expertise in the biotech and pharma sectors has made him a sought-after executive advisor and consultant.